Global and United States Nanostructured Drug Market Insights, Forecast to 2026

1 Study Coverage

• 1.1 Nanostructured Drug Product Introduction
• 1.2 Market Segments
• 1.3 Key Nanostructured Drug Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Nanostructured Drug Market Size Growth Rate by Type
  • 1.4.2 Liposomes
  • 1.4.3 Polymeric Micelles
  • 1.4.4 Solid lipid Nanoparticles
  • 1.4.5 Microemulsion and Nanoemulsion
  • 1.4.6 Nanosuspension
• 1.5 Market by Application
  • 1.5.1 Global Nanostructured Drug Market Size Growth Rate by Application
  • 1.5.2 Cancer and Tumors
  • 1.5.3 Autoimmune Disorders
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Nanostructured Drug Market Size, Estimates and Forecasts
  • 2.1.1 Global Nanostructured Drug Revenue 2015-2026
  • 2.1.2 Global Nanostructured Drug Sales 2015-2026
• 2.2 Global Nanostructured Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
• 2.3 Nanostructured Drug Historical Market Size by Region (2015-2020)
  • 2.3.1 Global Nanostructured Drug Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.3.2 Global Nanostructured Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
• 2.4 Nanostructured Drug Market Estimates and Projections by Region (2021-2026)
  • 2.4.1 Global Nanostructured Drug Sales Forecast by Region (2021-2026)
  • 2.4.2 Global Nanostructured Drug Revenue Forecast by Region (2021-2026)

3 Global Nanostructured Drug Competitor Landscape by Players

• 3.1 Global Top Nanostructured Drug Sales by Manufacturers
  • 3.1.1 Global Nanostructured Drug Sales by Manufacturers (2015-2020)
  • 3.1.2 Global Nanostructured Drug Sales Market Share by Manufacturers (2015-2020)
• 3.2 Global Nanostructured Drug Manufacturers by Revenue
  • 3.2.1 Global Nanostructured Drug Revenue by Manufacturers (2015-2020)
  • 3.2.2 Global Nanostructured Drug Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Nanostructured Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Nanostructured Drug Revenue in 2019
  • 3.2.5 Global Nanostructured Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Global Nanostructured Drug Price by Manufacturers
• 3.4 Global Nanostructured Drug Manufacturing Base Distribution, Product Types
  • 3.4.1 Nanostructured Drug Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Nanostructured Drug Product Type
  • 3.4.3 Date of International Manufacturers Enter into Nanostructured Drug Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Nanostructured Drug Market Size by Type (2015-2020)
  • 4.1.1 Global Nanostructured Drug Sales by Type (2015-2020)
  • 4.1.2 Global Nanostructured Drug Revenue by Type (2015-2020)
  • 4.1.3 Nanostructured Drug Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Nanostructured Drug Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Nanostructured Drug Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Nanostructured Drug Revenue Forecast by Type (2021-2026)
  • 4.2.3 Nanostructured Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Nanostructured Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Nanostructured Drug Market Size by Application (2015-2020)
  • 5.1.1 Global Nanostructured Drug Sales by Application (2015-2020)
  • 5.1.2 Global Nanostructured Drug Revenue by Application (2015-2020)
  • 5.1.3 Nanostructured Drug Price by Application (2015-2020)
• 5.2 Nanostructured Drug Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Nanostructured Drug Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Nanostructured Drug Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Nanostructured Drug Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

• 6.1 United States Nanostructured Drug Market Size YoY Growth 2015-2026
  • 6.1.1 United States Nanostructured Drug Sales YoY Growth 2015-2026
  • 6.1.2 United States Nanostructured Drug Revenue YoY Growth 2015-2026
  • 6.1.3 United States Nanostructured Drug Market Share in Global Market 2015-2026
• 6.2 United States Nanostructured Drug Market Size by Players (International and Local Players)
  • 6.2.1 United States Top Nanostructured Drug Players by Sales (2015-2020)
  • 6.2.2 United States Top Nanostructured Drug Players by Revenue (2015-2020)
• 6.3 United States Nanostructured Drug Historic Market Review by Type (2015-2020)
  • 6.3.1 United States Nanostructured Drug Sales Market Share by Type (2015-2020)
  • 6.3.2 United States Nanostructured Drug Revenue Market Share by Type (2015-2020)
  • 6.3.3 United States Nanostructured Drug Price by Type (2015-2020)
• 6.4 United States Nanostructured Drug Market Estimates and Forecasts by Type (2021-2026)
  • 6.4.1 United States Nanostructured Drug Sales Forecast by Type (2021-2026)
  • 6.4.2 United States Nanostructured Drug Revenue Forecast by Type (2021-2026)
  • 6.4.3 United States Nanostructured Drug Price Forecast by Type (2021-2026)
• 6.5 United States Nanostructured Drug Historic Market Review by Application (2015-2020)
  • 6.5.1 United States Nanostructured Drug Sales Market Share by Application (2015-2020)
  • 6.5.2 United States Nanostructured Drug Revenue Market Share by Application (2015-2020)
  • 6.5.3 United States Nanostructured Drug Price by Application (2015-2020)
• 6.6 United States Nanostructured Drug Market Estimates and Forecasts by Application (2021-2026)
  • 6.6.1 United States Nanostructured Drug Sales Forecast by Application (2021-2026)
  • 6.6.2 United States Nanostructured Drug Revenue Forecast by Application (2021-2026)
  • 6.6.3 United States Nanostructured Drug Price Forecast by Application (2021-2026)

7 North America

• 7.1 North America Nanostructured Drug Market Size YoY Growth 2015-2026
• 7.2 North America Nanostructured Drug Market Facts & Figures by Country
  • 7.2.1 North America Nanostructured Drug Sales by Country (2015-2020)
  • 7.2.2 North America Nanostructured Drug Revenue by Country (2015-2020)
  • 7.2.3 U.S.
  • 7.2.4 Canada

8 Europe

• 8.1 Europe Nanostructured Drug Market Size YoY Growth 2015-2026
• 8.2 Europe Nanostructured Drug Market Facts & Figures by Country
  • 8.2.1 Europe Nanostructured Drug Sales by Country
  • 8.2.2 Europe Nanostructured Drug Revenue by Country
  • 8.2.3 Germany
  • 8.2.4 France
  • 8.2.5 U.K.
  • 8.2.6 Italy
  • 8.2.7 Russia

9 Asia Pacific

• 9.1 Asia Pacific Nanostructured Drug Market Size YoY Growth 2015-2026
• 9.2 Asia Pacific Nanostructured Drug Market Facts & Figures by Country
  • 9.2.1 Asia Pacific Nanostructured Drug Sales by Region (2015-2020)
  • 9.2.2 Asia Pacific Nanostructured Drug Revenue by Region
  • 9.2.3 China
  • 9.2.4 Japan
  • 9.2.5 South Korea
  • 9.2.6 India
  • 9.2.7 Australia
  • 9.2.8 Taiwan
  • 9.2.9 Indonesia
  • 9.2.10 Thailand
  • 9.2.11 Malaysia
  • 9.2.12 Philippines
  • 9.2.13 Vietnam

10 Latin America

• 10.1 Latin America Nanostructured Drug Market Size YoY Growth 2015-2026
• 10.2 Latin America Nanostructured Drug Market Facts & Figures by Country
  • 10.2.1 Latin America Nanostructured Drug Sales by Country
  • 10.2.2 Latin America Nanostructured Drug Revenue by Country
  • 10.2.3 Mexico
  • 10.2.4 Brazil
  • 10.2.5 Argentina

11 Middle East and Africa

• 11.1 Middle East and Africa Nanostructured Drug Market Size YoY Growth 2015-2026
• 11.2 Middle East and Africa Nanostructured Drug Market Facts & Figures by Country
  • 11.2.1 Middle East and Africa Nanostructured Drug Sales by Country
  • 11.2.2 Middle East and Africa Nanostructured Drug Revenue by Country
  • 11.2.3 Turkey
  • 11.2.4 Saudi Arabia
  • 11.2.5 U.A.E

12 Company Profiles

• 12.1 Merck
  • 12.1.1 Merck Corporation Information
  • 12.1.2 Merck Description and Business Overview
  • 12.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
  • 12.1.4 Merck Nanostructured Drug Products Offered
  • 12.1.5 Merck Recent Development
• 12.2 Pfizer
  • 12.2.1 Pfizer Corporation Information
  • 12.2.2 Pfizer Description and Business Overview
  • 12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
  • 12.2.4 Pfizer Nanostructured Drug Products Offered
  • 12.2.5 Pfizer Recent Development
• 12.3 Novartis
  • 12.3.1 Novartis Corporation Information
  • 12.3.2 Novartis Description and Business Overview
  • 12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
  • 12.3.4 Novartis Nanostructured Drug Products Offered
  • 12.3.5 Novartis Recent Development
• 12.4 Abbott
  • 12.4.1 Abbott Corporation Information
  • 12.4.2 Abbott Description and Business Overview
  • 12.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
  • 12.4.4 Abbott Nanostructured Drug Products Offered
  • 12.4.5 Abbott Recent Development
• 12.5 GlaxoSmithKline
  • 12.5.1 GlaxoSmithKline Corporation Information
  • 12.5.2 GlaxoSmithKline Description and Business Overview
  • 12.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
  • 12.5.4 GlaxoSmithKline Nanostructured Drug Products Offered
  • 12.5.5 GlaxoSmithKline Recent Development
• 12.6 Roche
  • 12.6.1 Roche Corporation Information
  • 12.6.2 Roche Description and Business Overview
  • 12.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
  • 12.6.4 Roche Nanostructured Drug Products Offered
  • 12.6.5 Roche Recent Development
• 12.7 Sanofi
  • 12.7.1 Sanofi Corporation Information
  • 12.7.2 Sanofi Description and Business Overview
  • 12.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
  • 12.7.4 Sanofi Nanostructured Drug Products Offered
  • 12.7.5 Sanofi Recent Development
• 12.8 Eli Lilly
  • 12.8.1 Eli Lilly Corporation Information
  • 12.8.2 Eli Lilly Description and Business Overview
  • 12.8.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
  • 12.8.4 Eli Lilly Nanostructured Drug Products Offered
  • 12.8.5 Eli Lilly Recent Development
• 12.9 Astrazeneca
  • 12.9.1 Astrazeneca Corporation Information
  • 12.9.2 Astrazeneca Description and Business Overview
  • 12.9.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
  • 12.9.4 Astrazeneca Nanostructured Drug Products Offered
  • 12.9.5 Astrazeneca Recent Development
• 12.10 Johnson & Johnson
  • 12.10.1 Johnson & Johnson Corporation Information
  • 12.10.2 Johnson & Johnson Description and Business Overview
  • 12.10.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
  • 12.10.4 Johnson & Johnson Nanostructured Drug Products Offered
  • 12.10.5 Johnson & Johnson Recent Development
• 12.11 Merck
  • 12.11.1 Merck Corporation Information
  • 12.11.2 Merck Description and Business Overview
  • 12.11.3 Merck Sales, Revenue and Gross Margin (2015-2020)
  • 12.11.4 Merck Nanostructured Drug Products Offered
  • 12.11.5 Merck Recent Development
• 12.12 Novavax
  • 12.12.1 Novavax Corporation Information
  • 12.12.2 Novavax Description and Business Overview
  • 12.12.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
  • 12.12.4 Novavax Products Offered
  • 12.12.5 Novavax Recent Development
• 12.13 Stryker
  • 12.13.1 Stryker Corporation Information
  • 12.13.2 Stryker Description and Business Overview
  • 12.13.3 Stryker Sales, Revenue and Gross Margin (2015-2020)
  • 12.13.4 Stryker Products Offered
  • 12.13.5 Stryker Recent Development
• 12.14 Gilead Sciences
  • 12.14.1 Gilead Sciences Corporation Information
  • 12.14.2 Gilead Sciences Description and Business Overview
  • 12.14.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
  • 12.14.4 Gilead Sciences Products Offered
  • 12.14.5 Gilead Sciences Recent Development
• 12.15 OSI Pharmaceuticals
  • 12.15.1 OSI Pharmaceuticals Corporation Information
  • 12.15.2 OSI Pharmaceuticals Description and Business Overview
  • 12.15.3 OSI Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 12.15.4 OSI Pharmaceuticals Products Offered
  • 12.15.5 OSI Pharmaceuticals Recent Development
• 12.16 Kadmon Pharmaceuticals
  • 12.16.1 Kadmon Pharmaceuticals Corporation Information
  • 12.16.2 Kadmon Pharmaceuticals Description and Business Overview
  • 12.16.3 Kadmon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 12.16.4 Kadmon Pharmaceuticals Products Offered
  • 12.16.5 Kadmon Pharmaceuticals Recent Development
• 12.17 Samyang Biopharm
  • 12.17.1 Samyang Biopharm Corporation Information
  • 12.17.2 Samyang Biopharm Description and Business Overview
  • 12.17.3 Samyang Biopharm Sales, Revenue and Gross Margin (2015-2020)
  • 12.17.4 Samyang Biopharm Products Offered
  • 12.17.5 Samyang Biopharm Recent Development
• 12.18 Mitsubishi Pharma
  • 12.18.1 Mitsubishi Pharma Corporation Information
  • 12.18.2 Mitsubishi Pharma Description and Business Overview
  • 12.18.3 Mitsubishi Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 12.18.4 Mitsubishi Pharma Products Offered
  • 12.18.5 Mitsubishi Pharma Recent Development
• 12.19 Kaken Pharmaceutical
  • 12.19.1 Kaken Pharmaceutical Corporation Information
  • 12.19.2 Kaken Pharmaceutical Description and Business Overview
  • 12.19.3 Kaken Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 12.19.4 Kaken Pharmaceutical Products Offered
  • 12.19.5 Kaken Pharmaceutical Recent Development
• 12.20 Selecta Biosciences
  • 12.20.1 Selecta Biosciences Corporation Information
  • 12.20.2 Selecta Biosciences Description and Business Overview
  • 12.20.3 Selecta Biosciences Sales, Revenue and Gross Margin (2015-2020)
  • 12.20.4 Selecta Biosciences Products Offered
  • 12.20.5 Selecta Biosciences Recent Development
• 12.21 Par Pharmaceutical
  • 12.21.1 Par Pharmaceutical Corporation Information
  • 12.21.2 Par Pharmaceutical Description and Business Overview
  • 12.21.3 Par Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 12.21.4 Par Pharmaceutical Products Offered
  • 12.21.5 Par Pharmaceutical Recent Development
• 12.22 Cerulean Pharma
  • 12.22.1 Cerulean Pharma Corporation Information
  • 12.22.2 Cerulean Pharma Description and Business Overview
  • 12.22.3 Cerulean Pharma Sales, Revenue and Gross Margin (2015-2020)
  • 12.22.4 Cerulean Pharma Products Offered
  • 12.22.5 Cerulean Pharma Recent Development
• 12.23 Navidea Biopharmaceuticals
  • 12.23.1 Navidea Biopharmaceuticals Corporation Information
  • 12.23.2 Navidea Biopharmaceuticals Description and Business Overview
  • 12.23.3 Navidea Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 12.23.4 Navidea Biopharmaceuticals Products Offered
  • 12.23.5 Navidea Biopharmaceuticals Recent Development
• 12.24 Lummy
  • 12.24.1 Lummy Corporation Information
  • 12.24.2 Lummy Description and Business Overview
  • 12.24.3 Lummy Sales, Revenue and Gross Margin (2015-2020)
  • 12.24.4 Lummy Products Offered
  • 12.24.5 Lummy Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Nanostructured Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Nanostructured Drug Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details